AMERICAN SHARED HOSPITAL SERVICES Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $964.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q/A filed 2026-01-16.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-01-16
- AMERICAN SHARED HOSPITAL SERVICES right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $789.00K.
- AMERICAN SHARED HOSPITAL SERVICES right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-06-30 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-03-31 was $175.00K.
- AMERICAN SHARED HOSPITAL SERVICES right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-09-30 was $0.00.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month |
|---|---|---|---|
| 2025-09-30 | $789.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-01-16 | $789.00K derived: sum of 2 quarters · filed 2026-01-16 | $964.00K 10-Q/A · filed 2026-01-16 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $175.00K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $175.00K 10-Q · filed 2025-05-15 | ||
| 2024-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-01-16 | $0.00 derived: sum of 2 quarters · filed 2026-01-16 | $0.00 10-Q/A · filed 2026-01-16 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |